Myelogenous Leukemia
📧 Sign up to get email alerts when something new happens for Myelogenous Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases [Phase 1]
Phase 1 trial update on belinostat plus azacitidine in adults with advanced hematologic cancers. The study has completed enrollment and eval…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Open Label Phase II Study of BAY 43-9006 in Chronic Myelogenous Leukemia (CML) Patients Resistant to Gleevec [Phase 2]
Open-label Phase II study of sorafenib (BAY 43-9006) in chronic myelogenous leukemia patients resistant to imatinib (Gleevec) has completed.
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: Investigation of the Cylex® ImmuKnow® Assay
A completed clinical trial investigating the Cylex ImmuKnow immune function assay across several hematologic diseases.
-
CLINICAL_TRIALS trial_result · 2014-08-27Clinical Trial Update: Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia [Phase 1]
Phase 1 trial of vorinostat combined with decitabine in adults with advanced solid tumors or relapsed/refractory hematologic cancers, includ…
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer [NA]
This clinical-trial update reports completion and results posting for palifermin used to prevent chronic graft-versus-host disease in patien…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies [Phase 2]
Phase 2 clinical trial evaluating T-cell depleted allogeneic stem cell transplantation for hematologic malignancies; study is completed with…
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: PR1-Specific Cytotoxic T-Lymphocyte Infusion With Recurrent Chronic Myelogenous Leukemia (CML) After Allogeneic Hematopoietic Transplantation [Phase 1]
A Phase 1 trial evaluating PR1-specific cytotoxic T-lymphocyte infusion for recurrent chronic myelogenous leukemia after allogeneic hematopo…
-
CLINICAL_TRIALS trial_result · 2013-11-27Clinical Trial Update: Intraosseous Infusion of Unrelated Cord Blood Grafts [NA]
Clinical trial evaluating intraosseous infusion of unrelated cord blood grafts was terminated; sponsor was Emory University, and it studied …
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match [Phase 2]
Phase 2 trial evaluating pooled unrelated donor umbilical cord blood transplant for hematologic malignancies requiring allogeneic stem cell …
-
CLINICAL_TRIALS trial_result · 2013-10-24Clinical Trial Update: Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors [NA]
A completed clinical trial evaluating how imatinib affects bone metabolism in patients with chronic myelogenous leukemia or gastrointestinal…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes [Phase 1]
Phase 1 trial evaluating Tanespimycin in combination with Cytarabine in adults with relapsed or refractory acute myeloid leukemia, acute lym…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: SJG-136 in Treating Patients With Relapsed or Refractory Acute Leukemia, Myelodysplastic Syndromes, Blastic Phase Chronic Myelogenous Leukemia, or Chronic Lymphocytic Leukemia [Phase 1]
Phase 1 trial of SJG-136 in relapsed or refractory hematologic cancers (acute myeloid leukemia subtypes, myelodysplastic syndromes, blast-ph…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies [Phase 1]
A Phase 1 dose-escalation study of TAK-901 in subjects with advanced hematologic malignancies; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia [Phase 1, Phase 2]
This clinical trial update reports completion of Phase 1 and Phase 2 studies evaluating STI571 (imatinib) in combination with chemotherapy f…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Oblimersen and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia [Phase 2]
A Phase 2 study evaluated the combination of Oblimersen with Imatinib Mesylate in patients with chronic myelogenous leukemia, including BCR-…
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia [Phase 1]
A Phase 1 clinical trial of flavopiridol (alvocidib) in relapsed or refractory acute myeloid leukemia, acute lymphoblastic leukemia, or chro…
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia [Phase 2]
Phase 2 trial evaluating the combination of chemotherapy with peripheral stem cell transplantation for chronic myelogenous leukemia and acut…
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia [Phase 1]
Phase 1 trial evaluating a combination of imatinib mesylate and 17-N-allylamino-17-demethoxygeldanamycin in patients with chronic myelogenou…
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: XK469R in Treating Patients With Refractory Hematologic Cancer [Phase 1]
Phase 1 trial update reporting initial safety and tolerability findings for XK469R in patients with refractory hematologic cancers.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase [Phase 2]
A Phase 2 trial evaluating CCI-779 (temsirolimus) in adults with relapsed or refractory acute myeloid leukemia, acute lymphoblastic leukemia…
-
CLINICAL_TRIALS trial_result · 2013-01-03Clinical Trial Update: STI571 Compared With Interferon Alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia [Phase 3]
This document reports a Phase 3 trial comparing imatinib (STI571) with interferon alfa plus cytarabine in newly diagnosed chronic myeloid le…
-
CLINICAL_TRIALS trial_result · 2012-04-20Clinical Trial Update: A Phase 1/2 Study of SB1518 for the Treatment of Advanced Myeloid Malignancies [Phase 1, Phase 2]
This document provides an update on the completed Phase 1/2 trial of SB1518 for advanced myeloid malignancies.
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 clinical trial update for the CLAG-M regimen (cladribine, cytarabine, mitoxantrone, filgrastim) in relapsed acute lymphoblastic leuk…
-
CLINICAL_TRIALS trial_result · 2011-10-10Clinical Trial Update: Growth Factor Signature (GFS) Pilot Study (MK0000-098)(COMPLETED) [Phase 1]
A Phase 1 Growth Factor Signature (GFS) Pilot Study MK0000-098 in Philadelphia chromosome-positive chronic myelogenous leukemia and Philadel…
-
CLINICAL_TRIALS trial_result · 2011-08-03Clinical Trial Update: Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia [Phase 1]
This clinical trial update summarizes a Phase 1 study of a combination chemotherapy regimen in patients with chronic myelogenous leukemia an…